Why the study?
The study was conducted to quantify the prevalence of metabolic syndrome and depressive symptoms across racial/ethnic and socioeconomic strata in a nationally representative US sample.
Significant disparities exist in the prevalence of comorbid metabolic syndrome and depressive symptoms across socioeconomic strata in the US, highlighting the need for integrated, whole-person interventions.
Answers are grounded in this paper and cite their sources.
Socioeconomic disparities in comorbid metabolic syndrome and depressive symptoms may warrant targeted assessment; cross-sectional data leave open causality and intervention effects.
Objective: This study was conducted to quantify the prevalence of metabolic syndrome and depressive symptoms across racial/ethnic and socioeconomic strata in a nationally representative U.S. sample. Methods: We used National Health and Nutrition Examination Survey 2017-March 2020 data for participants aged 18 years and older. Prevalence of depressive symptoms and metabolic syndrome alone and in combination was measured across racial/ethnic, sex, age, and income strata. Chi-square tests were used for between-group comparisons. Those in the highest economic group were least likely to have either or both conditions. Conclusions: Disparities in comorbid conditions exist across socioeconomic and demographic strata. Achieving optimal and equitable health outcomes for people with these comorbidities will require "whole-person-in-context" interventions. Integrated approaches to coexisting medical, psychological, and social complexities are needed.
No takes yet. Share an insight, caveat, or question.
Dark et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: